“With implantation of CyPass®, many patients will need less medicine to control their eye pressure and some may not need prescription eye drops at all.”
Wyomissing, PA (PRWEB) April 26, 2017
Berks Eye Physicians & Surgeons Ltd. announced that they are now implanting the new Alcon CyPass® Micro-Stent, a micro invasive glaucoma surgical device. It is used to treat patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. Studies have shown the new FDA approved device provides a statistically significant decrease in post-surgical intraocular pressure.
Dr. Peter D. Calder, who was the first board-certified ophthalmologist in the area to implant the device, has seen a reduction in eye pressure after surgery for these patients. Berks Eye Physicians and Surgeons’ other cataract surgeons, Dr. Domenic C. Izzo, Jr. and Dr. Francisco L. Tellez, who is also a fellowship-trained glaucoma specialist, expect to be doing CyPass® Micro-Stent implants in the next several weeks.
Dr. Calder said, “With implantation of CyPass®, many patients will need less medicine to control their eye pressure and some may not need prescription eye drops at all.” The CyPass® Micro-Stent is implanted during cataract surgery, just below the surface of the eye, and is designed to lower eye pressure by enhancing aqueous outflow through one of the eye’s natural drainage pathways. Lowering the pressure inside of the eye is important to protect the optic nerve and to preserve vision in patients with glaucoma.